ASTM F1980-21 PDF
Name in English:
St ASTM F1980-21
Name in Russian:
Ст ASTM F1980-21
Original standard ASTM F1980-21 in PDF full version. Additional info + preview on request
Full title and description
Standard Guide for Accelerated Aging of Sterile Barrier Systems and Medical Devices (ASTM F1980-21). This guide provides recommended approaches for designing and interpreting accelerated aging studies intended to evaluate the time-related effects on sterile barrier systems (SBS) and, where applicable, medical device materials to support shelf-life and expiry-date claims.
Abstract
ASTM F1980-21 explains principles and practical considerations for developing accelerated aging protocols for sterile barrier systems and medical devices, including the use of accelerated aging factors (AAF/Q10 concepts), the relationship between accelerated and real-time aging, limitations of accelerated approaches, and guidance on when accelerated data may be considered supportive for expiry dating pending completion of real-time studies.
General information
- Status: Active (current edition F1980-21).
- Publication date: December 15, 2021.
- Publisher: ASTM International (ASTM).
- ICS / categories: 11.080.30 (Packaging).
- Edition / version: F1980-21 (2021).
- Number of pages: 8 pages.
Scope
This guide provides information to develop accelerated aging protocols that model the potential effects of the passage of time on the sterile integrity of sterile barrier systems (SBS) and the physical properties of component packaging materials. It may also be applied to medical devices and device materials. The guide clarifies that accelerated aging can be used as supporting evidence for expiry-date claims until real-time aging data are available and emphasizes that real-time studies must be conducted in parallel to confirm accelerated results. It excludes detailed real-time aging procedures, comprehensive package performance validation (environmental challenge, distribution/shipping events), and setting label storage conditions.
Key topics and requirements
- Principles of accelerated aging and use of accelerated aging factors (AAF/Q10).
- Design of accelerated aging protocols (temperature selection, duration calculation, and conservative vs. aggressive AAF choices).
- Requirement to run real-time aging studies in parallel and to use real-time data to confirm accelerated results.
- Limitations and exclusions: not intended for establishing label storage conditions or for simulating extreme environmental challenge events (referencing D4332 for conditioning).
- Emphasis on SI units and on exercising caution when applying Q10 values beyond validated material temperature ranges.
Typical use and users
Used by medical device manufacturers, packaging engineers, sterilization and validation specialists, regulatory and quality professionals, and contract test laboratories to design accelerated aging protocols, justify interim shelf-life claims, and plan complementary real-time stability studies. Typical applications include flexible and rigid sterile packaging systems (e.g., Tyvek pouches, film/foil systems, trays) for devices sterilized by EO, gamma, steam, or e-beam.
Related standards
ASTM F1980-21 references and aligns with international and ASTM practices for packaging and stability testing. Key related documents include ANSI/AAMI/ISO 11607-1 (packaging for terminally sterilized medical devices), ASTM Practice D4332 (conditioning for testing), and other ASTM F-series packaging and test-method standards.
Keywords
accelerated aging, sterile barrier system, SBS, shelf life, expiry date, Q10, accelerated aging factor, medical device packaging, stability, ASTM F1980-21.
FAQ
Q: What is this standard?
A: ASTM F1980-21 is a standard guide that provides recommendations for designing and interpreting accelerated aging studies for sterile barrier systems and medical devices to support shelf-life/expiry-date claims.
Q: What does it cover?
A: It covers the rationale, principles, and recommended approaches for accelerated aging protocol development (temperature selection, duration calculations using AAF/Q10 concepts), limitations of accelerated testing, and the requirement to confirm accelerated results with real-time aging. It does not prescribe specific real-time aging procedures or performance validation tests for distribution/shipping events.
Q: Who typically uses it?
A: Packaging and design engineers, sterilization and validation teams, quality/regulatory personnel, and contract test laboratories involved in medical device shelf-life assessment and packaging stability programs.
Q: Is it current or superseded?
A: The current edition is F1980-21 (published December 15, 2021) and is listed as active. A follow-up ASTM work item (WK94053) to revise the standard was initiated in 2025 to address a technical issue related to Q10 application; users should monitor ASTM committee activity for any official revision or amendment.
Q: Is it part of a series?
A: It is maintained by ASTM Committee F02 (Primary Barrier Packaging) and fits within the broader family of ASTM packaging standards and international packaging/sterilization documents (for example ANSI/AAMI/ISO 11607). It is commonly used alongside other F-series packaging and test-method standards.
Q: What are the key keywords?
A: Accelerated aging, sterile barrier system (SBS), shelf life, expiry date, Q10/AAF, medical device packaging, stability, validation.